RBB Fund, Inc.. Holdings as of May 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Travere Therapeutics IncTVTX | 7.67% | $8.05M | 170,714 |
| Cogent Biosciences IncCOGT | 7.53% | $7.91M | 226,142 |
| LivaNova PLC | 7.11% | $7.47M | 101,212 |
| Spyre Therapeutics IncSYRE | 6.41% | $6.73M | 91,588 |
| Guardant Health IncGH | 5.52% | $5.80M | 44,694 |
| Mirum Pharmaceuticals IncMIRM | 4.92% | $5.17M | 50,911 |
| Corcept Therapeutics IncCORT | 4.79% | $5.03M | 72,454 |
| United Therapeutics CorpUTHR | 4.16% | $4.37M | 7,841 |
| VeraDermics IncMANE | 3.42% | $3.59M | 35,568 |
| Savara IncSVRA | 3.22% | $3.39M | 651,024 |
| Cytokinetics IncCYTK | 3.16% | $3.32M | 43,268 |
| Nektar TherapeuticsNKTR | 3.14% | $3.30M | 50,876 |
| Trevi Therapeutics IncTRVI | 3.12% | $3.27M | 231,602 |
| Dianthus Therapeutics IncDNTH | 3.09% | $3.24M | 34,884 |
| Axsome Therapeutics IncAXSM | 2.84% | $2.98M | 12,723 |
| Billiontoone IncBLLN | 2.73% | $2.87M | 29,023 |
| TransMedics Group IncTMDX | 2.68% | $2.82M | 41,894 |
| Viridian Therapeutics IncVRDN | 2.23% | $2.35M | 133,261 |
| ICU Medical IncICUI | 2.09% | $2.20M | 16,227 |
| Corvus Pharmaceuticals IncCRVS | 1.95% | $2.05M | 165,305 |
| Palvella Therapeutics IncPVLA | 1.95% | $2.04M | 17,254 |
| Ceribell IncCBLL | 1.55% | $1.63M | 88,354 |
| Globus Medical IncGMED | 1.27% | $1.33M | 16,258 |
| Xeris Biopharma Holdings IncXERS | 1.22% | $1.28M | 207,543 |
| Bridgebio Pharma IncBBIO | 1.17% | $1.23M | 18,534 |
| Integer Holdings CorpITGR | 1.14% | $1.20M | 13,436 |
| Twist Bioscience CorpTWST | 1.14% | $1.19M | 17,850 |
| F/m Ultrashort Treasury Inflat | 1.08% | $1.14M | 22,751 |
| Waystar Holding CorpWAY | 1.05% | $1.10M | 55,155 |
| WaVe Life Sciences Ltd | 0.95% | $1.00M | 152,008 |
| Hinge Health IncHNGE | 0.94% | $988.73K | 17,590 |
| Korro Bio IncKRRO | 0.80% | $842.89K | 62,855 |
| RadNet IncRDNT | 0.79% | $827.34K | 14,899 |
| Aveanna Healthcare Holdings InAVAH | 0.72% | $758.44K | 105,779 |
| Lumexa Imaging Holdings IncLMRI | 0.70% | $738.92K | 94,977 |
| Insmed IncINSM | 0.62% | $646.81K | 6,050 |
| Alphatec Holdings IncATEC | 0.57% | $599.74K | 77,386 |
| NeoGenomics IncNEO | 0.43% | $453.11K | 43,071 |
| Alamar Biosciences IncALMR | 0.18% | $192.99K | 9,442 |
| U.S. Bank Money Market Deposit AccountCash or money market | 0.00% | $203 | 203 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.